Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Which Switch Game Do You Suggest? Share Your Decision - 2New movies to watch this weekend: See 'Predator: Badlands' in theaters, rent 'Black Phone 2,' stream Guillermo del Toro's 'Frankenstein' on Netflix
- 3Choosing Moving Styles for Your Restroom Redesign
- 4FDA proposes use of sunscreen ingredient popular in other countries
- 55 Chiefs That Changed Our Opinion on Film
- Instructions to Pick the Best Album Rates for Your Investment funds
- Grasping Various Kinds of Local misdemeanors
- Midlife weight gain can start long before menopause – but you can take steps early on to help your body weather the hormonal shift
- Chinese astronauts’ return to Earth delayed over fears spaceship damaged by debris
- Family Matters: Tips and Guidance for Effective Nurturing and Everyday Life
- Holiday spots Well known With Americans In 2024
- 4 injured in shooting at North Carolina tree lighting ceremony
- Vote in favor of your Favored Travel Movement
- Astronomers discover never-before-seen celestial object: "Cloud 9"
